Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.

BACKGROUND:The present study aimed to investigate the impact of pre-sarcopenia on the prognosis of patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. METHODS:We enrolled 214 patients (71 ± 10 years old; 166 men and 48 women; 90% Child-Pugh grade A and 10% Child-Pugh grade...

Full description

Bibliographic Details
Main Authors: Hitomi Takada, Masayuki Kurosaki, Hiroyuki Nakanishi, Yuka Takahashi, Jun Itakura, Kaoru Tsuchiya, Yutaka Yasui, Nobuharu Tamaki, Kenta Takaura, Yasuyuki Komiyama, Mayu Higuchi, Youhei Kubota, Wann Wang, Mao Okada, Nobuyuki Enomoto, Namiki Izumi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6005492?pdf=render

Internet

http://europepmc.org/articles/PMC6005492?pdf=render

Similar Items